Prescribed Health Apps Market Size Is Projected to Grow at a 47.1 % CAGR By 2023
Prescribed Health Apps Market Research By Operating System ( Windows , Androids , iPhones ) By Devices ( Diabetes management device , multi-parameter tracker , cardiac monitoring device ) and End User Analysis By New Technology , Trends and Global Industry Forecast to 2024
Market Outlook
The global
prescribed health apps market is predicted to exhibit a stupendous 47.1 % CAGR from 2017 to 2023 ( forecast period ). It is driven by the preference of mobile healthcare solutions amid the high penetration rate of smartphones and smart devices . According to the National Center for Biotechnology Information ( NCBI ), 68 % of patients in the U . S . use a mobile health ( mHealth ) application for gaining advice on health problems and booking appointments .
The ubiquitousness of smartphones and smart devices have ensured the development of mobile applications . Prescribed health apps are software applications designed to provide health services over mobile devices . They assist patients by managing their medical condition in real-time and gaining advice from medical professionals via the mobile phone . The global prescribed health apps market report by Market Research Future encompasses numerous drivers and restraints which can enlighten readers and facilitate in making right investment decisions .
Rise in healthcare facilities and medical professionals jumping on board the digital application bandwagon can bode well for the market . Presence of advanced telecommunication networks and a plethora of platforms for professionals to offer their expertise to patients can bolster the global prescribed health apps market demand in the coming years . The use of mobile applications by healthcare consumers is a positive indicator of the potential of the market . Seed funding and rising interest by venture capital firms can boost the market demand . In 2019 , Xealth , a U . S . company gained funding from Philips , Novartis , ResMed , and McKesson Ventures .
Lack of patient awareness and hazy policies concerning patient information can pose a challenge to the market growth .
Segmentation Analysis